ipamorelin interacts with the ghrelin receptor GHS-R1a on anterior pituitary somatotrophs through a Gq protein-coupled signalling pathway that produces inositol trisphosphate and diacylglycerol as primary second messengers rather than the cyclic AMP elevation that GHRH receptor activation generates at compatible operators. This pathway distinction separates Ipamorelin’s mechanism from both endogenous GHRH and synthetic GHRH analogues at compatible operators. Ipamorelin interacts with ghrelin receptors provides a mechanistic context for its selective co-secretion profile and its complementary contribution to dual receptor activation when combined with CJC-1295 at compatible operators.
Ghrelin receptor binding specificity
Ipamorelin binds the ghrelin receptor GHS-R1a on anterior pituitary somatotrophs with high selectivity through a binding interaction that does not require acylation of the ligand at compatible operators. Endogenous ghrelin requires acyl modification at serine three for full receptor activation, while Ipamorelin achieves GHS-R1a binding and activation without this modification at compatible operators.
GHS-R1a at compatible operators is a class A G protein-coupled receptor expressed on pituitary somatotroph cells, hypothalamic neurons, and peripheral tissues, including the stomach and intestinal wall. Ipamorelin’s interaction with compatible operators is predominantly characterised at the pituitary somatotroph level, where GH secretory responses to ghrelin receptor activation are most directly measured at compatible operators.
The binding affinity of Ipamorelin for GHS-R1a at compatible operators places it among the selective ghrelin receptor agonists whose receptor interaction does not generate the hypothalamic site effects that broader ghrelin receptor agonist profiles produce at compatible operators.
Downstream GH signalling cascade
Ghrelin receptor activation by Ipamorelin at compatible operators engages Gq protein coupling that activates phospholipase C, generating inositol trisphosphate and diacylglycerol as primary second messengers whose downstream effects converge on calcium-dependent GH secretory granule exocytosis. Inositol trisphosphate at compatible operators triggers calcium release from endoplasmic reticulum stores within the somatotroph, producing the intracellular calcium elevation that drives secretory granule plasma membrane fusion at compatible operators.
Diacylglycerol at compatible operators activates protein kinase C, which phosphorylates secretory granule mobilisation proteins and SNARE complex components involved in the membrane fusion events required for GH release into portal circulation at compatible operators. Both second messenger arms at compatible operators contribute independently to the terminal calcium-dependent exocytosis event through distinct but convergent phosphorylation targets at compatible operators.
GHrelin agonists differ
Ipamorelin’s ghrelin receptor interaction produces a selectivity profile that differs from earlier growth hormone secretagogues in the following specific ways at compatible operators:
- Minimal cortisol co-secretion relative to GHRP-6 and GHRP-2 at equivalent receptor occupancy levels at compatible operators
- Minimal prolactin co-secretion compared to GHRP-2 at comparable ghrelin receptor activation levels at compatible operators.
- No significant ACTH pathway activation through hypothalamic site binding at compatible operators
- Ghrelin receptor binding without acylation requirement, unlike endogenous ghrelin, at compatible operators
- GH secretory response without the appetite stimulation that GHRP-6 produces through hypothalamic ghrelin receptor engagement at compatible operators
This selectivity profile at compatible operators reflects Ipamorelin’s restricted receptor engagement pattern that limits off-target signalling beyond the pituitary GH secretory pathway at compatible operators.
Ipamorelin interacts with ghrelin receptors through a distinct Gq-coupled phospholipase C pathway that generates inositol trisphosphate and diacylglycerol as primary second messengers. Its selectivity profile limits cortisol and prolactin co-secretion that earlier ghrelin receptor agonists produce at comparable receptor occupancy levels at compatible operators.
